160 related articles for article (PubMed ID: 31364732)
21. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells.
Zi D; Zhou ZW; Yang YJ; Huang L; Zhou ZL; He SM; He ZX; Zhou SF
Int J Mol Sci; 2015 Nov; 16(11):27228-51. PubMed ID: 26580601
[TBL] [Abstract][Full Text] [Related]
22. FGF18 Enhances Migration and the Epithelial-Mesenchymal Transition in Breast Cancer by Regulating Akt/GSK3β/Β-Catenin Signaling.
Song N; Zhong J; Hu Q; Gu T; Yang B; Zhang J; Yu J; Ma X; Chen Q; Qi J; Liu Y; Su W; Feng Z; Wang X; Wang H
Cell Physiol Biochem; 2018; 49(3):1019-1032. PubMed ID: 30196303
[TBL] [Abstract][Full Text] [Related]
23. CD24 gene inhibition and TIMP-4 gene upregulation by Imperata cylindrica's root extract prevents metastasis of CaSki cells via inhibiting PI3K/Akt/snail signaling pathway and blocking EMT.
Nayim P; Mbaveng AT; Sanjukta M; Rikesh J; Kuete V; Sudhir K
J Ethnopharmacol; 2021 Jul; 275():114111. PubMed ID: 33848610
[TBL] [Abstract][Full Text] [Related]
24. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
[TBL] [Abstract][Full Text] [Related]
25. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.
Yang HL; Thiyagarajan V; Shen PC; Mathew DC; Lin KY; Liao JW; Hseu YC
J Exp Clin Cancer Res; 2019 May; 38(1):186. PubMed ID: 31068208
[TBL] [Abstract][Full Text] [Related]
26. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
27. Combretastatin A4 Regulates Proliferation, Migration, Invasion, and Apoptosis of Thyroid Cancer Cells via PI3K/Akt Signaling Pathway.
Liang W; Lai Y; Zhu M; Huang S; Feng W; Gu X
Med Sci Monit; 2016 Dec; 22():4911-4917. PubMed ID: 27966519
[TBL] [Abstract][Full Text] [Related]
28. BDE-99 (2,2',4,4',5-pentabromodiphenyl ether) triggers epithelial-mesenchymal transition in colorectal cancer cells via PI3K/Akt/Snail signaling pathway.
Wang F; Ruan XJ; Zhang HY
Tumori; 2015; 101(2):238-45. PubMed ID: 25908029
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
[TBL] [Abstract][Full Text] [Related]
30. Nicotine promotes cervical carcinoma cell line HeLa migration and invasion by activating PI3k/Akt/NF-κB pathway in vitro.
Wang C; Gu W; Zhang Y; Ji Y; Wen Y; Xu X
Exp Toxicol Pathol; 2017 Jul; 69(6):402-407. PubMed ID: 28385482
[TBL] [Abstract][Full Text] [Related]
31. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
[TBL] [Abstract][Full Text] [Related]
32. Osthole inhibits insulin-like growth factor-1-induced epithelial to mesenchymal transition via the inhibition of PI3K/Akt signaling pathway in human brain cancer cells.
Lin YC; Lin JC; Hung CM; Chen Y; Liu LC; Chang TC; Kao JY; Ho CT; Way TD
J Agric Food Chem; 2014 Jun; 62(22):5061-71. PubMed ID: 24828835
[TBL] [Abstract][Full Text] [Related]
33. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
34. PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway.
Lin Y; Yang Z; Xu A; Dong P; Huang Y; Liu H; Li F; Wang H; Xu Q; Wang Y; Sun D; Zou Y; Zou X; Wang Y; Zhang D; Liu H; Wu X; Zhang M; Fu Y; Cai Z; Liu C; Wu S
Sci Rep; 2015 Mar; 5():8997. PubMed ID: 25757764
[TBL] [Abstract][Full Text] [Related]
35. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
Lee YJ; Han HJ
Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
[TBL] [Abstract][Full Text] [Related]
36. α-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and β-catenin stabilization in cervical cancer.
An HT; Yoo S; Ko J
Oncogene; 2016 Nov; 35(45):5893-5904. PubMed ID: 27065319
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA‑126‑3p suppresses HeLa cell proliferation, migration and invasion, and increases apoptosis via the PI3K/PDK1/AKT pathway.
Ichikawa R; Kawasaki R; Iwata A; Otani S; Nishio E; Nomura H; Fujii T
Oncol Rep; 2020 Apr; 43(4):1300-1308. PubMed ID: 32323808
[TBL] [Abstract][Full Text] [Related]
38. TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway.
Chen L; Qing J; Xiao Y; Huang X; Chi Y; Chen Z
BMC Cancer; 2022 Apr; 22(1):370. PubMed ID: 35392845
[TBL] [Abstract][Full Text] [Related]
39. Rhapontigenin inhibits TGF-β-mediated epithelial‑mesenchymal transition via the PI3K/AKT/mTOR pathway and is not associated with HIF-1α degradation.
Yeh YH; Wang SW; Yeh YC; Hsiao HF; Li TK
Oncol Rep; 2016 May; 35(5):2887-95. PubMed ID: 26986649
[TBL] [Abstract][Full Text] [Related]
40. COX‑2 promotes epithelial‑mesenchymal transition and migration in osteosarcoma MG‑63 cells via PI3K/AKT/NF‑κB signaling.
Zhang X; Qu P; Zhao H; Zhao T; Cao N
Mol Med Rep; 2019 Oct; 20(4):3811-3819. PubMed ID: 31485669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
